Clinical Trials
9
Active:0
Completed:9
Trial Phases
2 Phases
Phase 1:2
Phase 2:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 2
7 (77.8%)Phase 1
2 (22.2%)An Open-label Study That Will Test a Second Treatment Session of RZL-012.
- First Posted Date
- 2023-03-10
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Raziel Therapeutics Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT05763160
- Locations
- 🇺🇸
Luxurgery, Manhattan, New York, United States
Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events
Phase 1
Completed
- Conditions
- Submental Fat
- Interventions
- Drug: RZL-012+Lidacaine injection prior treatmentDrug: RZL-012+MedrolDrug: RZL-012+Celecoxib+ZyrtecDrug: RZL-012+facial and neck wrap
- First Posted Date
- 2022-07-27
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Raziel Therapeutics Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT05476679
- Locations
- 🇺🇸
Luxurgery, Manhattan, New York, United States
An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects.
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- Raziel Therapeutics Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT05466448
- Locations
- 🇺🇸
Luxurgery, New York, New York, United States
Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks
- First Posted Date
- 2022-07-06
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Raziel Therapeutics Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT05445557
- Locations
- 🇺🇸
Luxurgery, New York, New York, United States
Efficacy and Safety of RZL-012 on Submental Fat Reduction
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Raziel Therapeutics Ltd.
- Target Recruit Count
- 151
- Registration Number
- NCT04867434
- Locations
- 🇺🇸
DenovaResearch, Chicago, Illinois, United States
- Prev
- 1
- 2
- Next
News
No news found